CD8A and neoplasm: The potential mechanisms were revealed by clinical and immune characteristics, such as high expression of PD-L1, high tumor mutational burden (TMB-H), Epstein-Barr virus (EBV) positive and CD8<sup>+</sup> tumor-infiltrating lymphocyte positive.